Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/9/2024 | $45.00 | Market Perform → Outperform | BMO Capital Markets |
| 10/31/2024 | $49.00 | Neutral → Outperform | Exane BNP Paribas |
| 10/18/2024 | $45.00 | Buy | Berenberg |
| 7/25/2024 | $34.00 → $35.00 | Outperform → Neutral | Mizuho |
| 3/22/2024 | $32.00 → $35.00 | Neutral → Buy | Citigroup |
| 2/26/2024 | $31.00 → $35.00 | Equal Weight → Overweight | Wells Fargo |
| 2/8/2024 | $30.00 | Underperform → Neutral | Exane BNP Paribas |
| 1/30/2024 | $36.00 | Buy | Deutsche Bank |
BMO Capital Markets upgraded Omega Health from Market Perform to Outperform and set a new price target of $45.00
Exane BNP Paribas upgraded Omega Health from Neutral to Outperform and set a new price target of $49.00
Berenberg initiated coverage of Omega Health with a rating of Buy and set a new price target of $45.00
Omega Healthcare Investors, Inc. (NYSE:OHI) announced today that it is scheduled to release its earnings results for the quarter ended December 31, 2024, on Wednesday, February 5, 2025, after market close. In conjunction with its release, Omega will be conducting a conference call on Thursday, February 6, 2025, at 10 a.m. Eastern Time to review its 2024 fourth quarter results and current developments. To listen to the conference call via webcast, log on to www.omegahealthcare.com and click the "4Q 2024 Earnings Call" hyperlink on the "Investors" page of Omega's website. Webcast replays of the call will be available on Omega's website for approximately two weeks following the call. Additio
Omega Healthcare Investors, Inc. (NYSE:OHI) (the "Company" or "Omega") today announced key leadership changes. Matthew Gourmand, previously Senior Vice President, Corporate Strategy & Investor Relations, has been appointed President, and Vikas Gupta, previously Senior Vice President, Acquisitions & Development, has been appointed Chief Investment Officer. Separately, after 23 years as Chief Operating Officer, Dan Booth has stepped down from his position and is expected to remain in a consulting role for a period of 12 months. Taylor Pickett, Omega's Chief Executive Officer, stated, "The Company has been fortunate to enjoy a stable executive team for many years, while augmenting the long-s
Completed $834 Million in New Investments Year-to-Date Increased Full Year Adjusted FFO Guidance Omega Healthcare Investors, Inc. (NYSE:OHI) (the "Company" or "Omega") announced today its results for the quarter ended September 30, 2024. THIRD QUARTER 2024 AND RECENT HIGHLIGHTS Net income for the quarter of $115 million, or $0.42 per common share, compared to $94 million, or $0.37 per common share, for Q3 2023. Nareit Funds From Operations ("Nareit FFO") for the quarter of $196 million, or $0.71 per common share, on 276 million weighted-average common shares outstanding, compared to $161 million, or $0.63 per common share, on 256 million weighted-average common shares outstanding, fo
4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)
4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)
4 - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Issuer)
Omega Healthcare Investors, Inc. (NYSE:OHI) announced today that it is scheduled to release its earnings results for the quarter ended December 31, 2024, on Wednesday, February 5, 2025, after market close. In conjunction with its release, Omega will be conducting a conference call on Thursday, February 6, 2025, at 10 a.m. Eastern Time to review its 2024 fourth quarter results and current developments. To listen to the conference call via webcast, log on to www.omegahealthcare.com and click the "4Q 2024 Earnings Call" hyperlink on the "Investors" page of Omega's website. Webcast replays of the call will be available on Omega's website for approximately two weeks following the call. Additio
Completed $834 Million in New Investments Year-to-Date Increased Full Year Adjusted FFO Guidance Omega Healthcare Investors, Inc. (NYSE:OHI) (the "Company" or "Omega") announced today its results for the quarter ended September 30, 2024. THIRD QUARTER 2024 AND RECENT HIGHLIGHTS Net income for the quarter of $115 million, or $0.42 per common share, compared to $94 million, or $0.37 per common share, for Q3 2023. Nareit Funds From Operations ("Nareit FFO") for the quarter of $196 million, or $0.71 per common share, on 276 million weighted-average common shares outstanding, compared to $161 million, or $0.63 per common share, on 256 million weighted-average common shares outstanding, fo
Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company's Board of Directors declared a cash dividend of $0.67 per share on its common stock. The dividend is payable Friday, November 15, 2024, to common stockholders of record as of the close of business on Monday, November 4, 2024. Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK. More information on Omega is available at www.omeg
NEW YORK, March 10, 2021 /PRNewswire/ -- Maplewood Senior Living and Omega Healthcare Investors, Inc. (NYSE: OHI) today announced the official opening of Inspīr Carnegie Hill, the new luxury senior living community on Manhattan's Upper East Side. Inspīr Carnegie Hill is a next-generation concept for urban senior living on a luxury level, offering residents a transformative, one-of-a-kind experience made possible by combining expertise and insights from the residential, hospitality and healthcare industries. Featuring state-of-the-art spaces, exceptional care, intelligent technology and immersive experiences, Inspīr Carnegie Hill has curated an environment and lifestyle that supports a philos
SC 13G/A - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Subject)
SC 13G/A - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Subject)
SC 13G/A - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Subject)
8-K - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Filer)
10-Q - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Filer)
8-K - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Filer)